Sign in
Editorial - Moving forward on the pathway of targeted immunotherapies for type 1 diabetes: the importance of disease heterogeneity
Journal article

Editorial - Moving forward on the pathway of targeted immunotherapies for type 1 diabetes: the importance of disease heterogeneity

M Infante and C Ricordi
European review for medical and pharmacological sciences, Vol.23(19), pp.8702-8704
2019-10
PMID: 31646605

Abstract

Diabetes Mellitus, Type 1 - immunology Diabetes Mellitus, Type 1 - pathology Diabetes Mellitus, Type 1 - therapy Humans Immunotherapy

Metrics

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
International collaboration
Citation topics
1 Clinical & Life Sciences
1.26 Diabetes
1.26.1016 Type 1 Diabetes
Web Of Science research areas
Pharmacology & Pharmacy
ESI research areas
Pharmacology & Toxicology

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Details

Logo image